Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
Individual results may vary based on age, baseline tissue health, and adherence to the prescribed protocol
The options may be chosen on the product page Save $40 Select options This product has multiple variants
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
This product is supplied for research purposes only and is not offered for human or veterinary use
Not exactly AOD-9604 is a modified version of the natural fragment, designed to be more stable and active
